Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25045811 | 0.89 | CA1 (0.39) | CA1CA2ALOX15 | |
| SCHEMBL11138013 | 0.81 | CA1 (0.45) | CA1CA2ALDH1A1 | |
| SCHEMBL7367907 | 0.81 | DDAH1 (0.33) | CA1CA2ALOX15 | |
| SCHEMBL2557758 | 0.80 | SMN1; SMN2 (0.38) | CA2ALDH1A1 | |
| SCHEMBL6395180 | 0.79 | — | — | |
| SCHEMBL28396026 | 0.79 | ACHE (0.32) | ALDH1A1 | |
| SCHEMBL27447790 | 0.77 | ALDH1A1 (0.37) | ALDH1A1ALOX15 | |
| SCHEMBL1259256 | 0.76 | CA1 (0.34) | CA1CA2ALOX15 | |
| SCHEMBL23850372 | 0.75 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL23230292 | 0.74 | CA1 (0.33) | CA1CA2ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255088-A1 | DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS | PROTOCELL THERAPEUTICS INC. | 2008-10-16 | — | — | US | disclosed |
| US-4325973-A | Hydroxyalkyl amides as fungicides to eumycotina in phanerogamia plant life | GAF CORPORATION (US) | 1982-04-20 | — | — | US | disclosed |
| US-4195096-A | NONTOXIC, BIODEGRADABLE | GAF CORPORATION (US) | 1980-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255088-A1 | DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS | DBH, DRD4, PSEN1 | CA1 3287/4885CA2 4707/4885ALDH1A1 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.